RankingsPricing
  1. US-listed companies
  2. BOSTON SCIENTIFIC CORP
  3. Financials
  4. Cash from investing

BOSTON SCIENTIFIC CORPBSX

Market cap
$145B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-5,687+120.94%
Dec 31, 2023-2,574+28.00%
Dec 31, 2022-2,011+25.92%
Dec 31, 2021-1,597+288.56%
Dec 31, 2020-411-91.85%
Dec 31, 2019-5,041+162.42%
Dec 31, 2018-1,921+90.20%
Dec 31, 2017-1,010+13.87%
Dec 31, 2016-887-59.42%
Dec 31, 2015-2,186+193.42%
Dec 31, 2014-745+56.84%
Dec 31, 2013-475-17.96%
Dec 31, 2012-579-175.29%
Dec 31, 2011769-260.21%
Dec 31, 2010-480

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)